These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26372881)

  • 1. Immune control of oncogenic γ-herpesviruses.
    Jung J; Münz C
    Curr Opin Virol; 2015 Oct; 14():79-86. PubMed ID: 26372881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
    Damania B; Münz C
    FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses.
    Münz C
    Viruses; 2021 May; 13(5):. PubMed ID: 34066671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis.
    Zhang X; Dawson CW; He Z; Huang P
    J Med Virol; 2012 Feb; 84(2):272-81. PubMed ID: 22170548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
    Böni M; Rieble L; Münz C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
    Münz C
    Front Immunol; 2020; 11():581419. PubMed ID: 33013936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.
    Münz C
    Front Immunol; 2018; 9():238. PubMed ID: 29483919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion.
    Nash A; Ryan EJ
    Tumour Virus Res; 2022 Dec; 14():200246. PubMed ID: 35998812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
    McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
    Münz C
    Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflections on Epstein-Barr virus: some recently resolved old uncertainties.
    Epstein MA
    J Infect; 2001 Aug; 43(2):111-5. PubMed ID: 11676516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
    Münz C
    J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice.
    Schuhmachers P; Münz C
    Front Immunol; 2021; 12():640918. PubMed ID: 33833760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.
    Hassan STS; Šudomová M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic effects of exosomes in γ-herpesvirus-associated neoplasms.
    Zheng J; Shi Y; Feng Z; Zheng Y; Li Z; Zhao Y; Wang Y
    J Cell Physiol; 2019 Nov; 234(11):19167-19179. PubMed ID: 30941765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.
    Zheng D; Wan J; Cho YG; Wang L; Chiou CJ; Pai S; Woodard C; Zhu J; Liao G; Martinez-Maza O; Qian J; Zhu H; Hayward GS; Ambinder RF; Hayward SD
    J Infect Dis; 2011 Dec; 204(11):1683-91. PubMed ID: 21990424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.
    Münz C
    Front Cell Infect Microbiol; 2021; 11():605258. PubMed ID: 33842383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.
    Sallah N; Miley W; Labo N; Carstensen T; Fatumo S; Gurdasani D; Pollard MO; Dilthey AT; Mentzer AJ; Marshall V; Cornejo Castro EM; Pomilla C; Young EH; Asiki G; Hibberd ML; Sandhu M; Kellam P; Newton R; Whitby D; Barroso I
    Nat Commun; 2020 Jul; 11(1):3849. PubMed ID: 32737300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.